[Significance of cardiac arrhythmia in mitral valve prolapse syndrome].
Werdan
K
K
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000175:diagnosis* / Q000188:drug therapy; D003645:Death, Sudden / Q000209:etiology; D004562:Electrocardiography; D006801:Humans; D008945:Mitral Valve Prolapse / Q000175:diagnosis* / Q000188:drug therapy; D011226:Pre-Excitation Syndromes / Q000175:diagnosis; D012306:Risk; D013577:Syndrome
D000889:Anti-Arrhythmia Agents
Bedeutung von Herzrhythmusstörungen beim Mitralklappenprolaps-Syndrom.